Navigation Links
ALS Therapy Development Institute Delivers Impassioned Testimony to Congressional Subcommittee on Veterans Affairs

Physician/Scientist Describes a New Challenge Faced by Troops Coming Home from War

CAMBRIDGE, Mass., April 28 /PRNewswire-USNewswire/ -- Dr. Stanley Appel testified before theMilitary Construction and Veterans Affairs Appropriations Subcommittee on behalf of ALS patients, and in support of the ALS Therapy Development Institute (ALS TDI), last Thursday. Dr. Appel urged congress to support a comprehensive approach to ALS therapeutic development, such as the one at ALS TDI.

Dr. Appel spoke on the still unknown reasons for the connection between service in the armed forces and a greater propensity for developing the disease. He advised Subcommittee members to remember that, while there is excellent work being done to determine factors involved in the military correlation, without a comprehensive and well funded program to build therapeutics, there would be no opportunity to treat fallen heroes.

"I am here before this subcommittee -- responsible for supporting our veterans -- because [ALS] continues to take an inordinate toll on our nation's veterans," said Dr. Appel in his prepared testimony before the subcommittee. Dr. Appel, co-director of the Methodist Neurological Institute, has been a physician/scientist for more than 40 years and is a Board Member of ALS TDI, as well as the Muscular Dystrophy Association.

As he began his testimony, Dr. Appel acknowledged the leadership of Congressman Michael Capuano, along with Congressmen Patrick Kennedy, Henry Brown and John Spratt in addressing the need to bring effective therapeutics to market for ALS patients.

In discussing the VA's now closed ALS Registry, Dr. Appel honored its list of servicemen; "While most of those heroes have passed away, the numbers imply that at least one out of fifteen ALS patients has a history of military service. This is quite staggering. These veterans, and all the patients I treat, are facing a horrifying illness; a battle with no armor," continued Dr. Appel. "We have the responsibility to arm our service members in the final battle they are currently only to lose. The thousands, who have recently returned from engagement, and those soon to come home, may in fact encounter a final new enemy in ALS."

Amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) is a progressive neurodegenerative disease that affects approximately 30,000 people living in the United States at any given time. According to Dr. Appel's testimony, more than 2,000 veterans registered as suffering from ALS when the Department of Veterans Affairs initiated its voluntary ALS Registry in 2003.

The subcommittee, chaired by Congressman Chet Edwards, known as a national champion for America's veterans, troops, and their families, is responsible for the appropriation of funds for a variety of military related accounts, including all funds administered by the Department of Veterans Affairs. Under Edwards' leadership, the subcommittee has increased appropriations for veteran's benefits and health care by $16.3 billion since 2007.

"ALS is not an incurable disease. It is an underfunded disease. The science is ready, the technology is ready, we clinicians are ready." Dr. Stanley Appel's complete testimony before the subcommittee is available online at


The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that stop ALS as soon as possible. Focused on meeting this urgent unmet medical need, ALS TDI executes a robust discovery program, as well as a multi-pronged approach to validate potential therapeutics; including small molecules, protein biologics, gene therapies and cell-based constructs. The Institute's unique, industrial-scale platform allows for the development and testing of dozens of potential therapeutics each year. Built by and for patients, the Institute is the world's only non-profit biotechnology company with more than 30 professional scientists. In addition, the Cambridge, Massachusetts based research Institute collaborates with leaders in both academia and industry. For more information, please visit us online at

SOURCE ALS Therapy Development Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Prostate cancer therapy increases risk of fractures and cardiovascular-related death
2. Says News Legislation Could Affect Physical, Speech Therapy Benefits for Medicare Recipients
3. Drug therapy reduces neuroblastoma tumor growth in pre-clinical investigation
4. CIDP Treated With Plasma-Derived Therapy
5. G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab
6. Elekta Contract Provides MAGNET Cooperative Access to Leading Radiation Therapy Solutions
7. Hormone therapy offers potential protective effect against colon cancer in older women
8. RapidArc Radiotherapy Technology Enabling Fast, Accurate Treatments for Pennsylvania Cancer Patients
9. Illinois-Based AthletiCo Opens Milestone 50th Physical Therapy Center
10. Medical Tourism is Good Therapy for the Hotel Industry
11. Photos: NeuroStar TMS Therapy(R) Recipient of Medical Design Excellence Award
Post Your Comments:
(Date:12/1/2015)... ... ... is the first health care provider in the region to offer the vBloc® Therapy ... vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients over ... to 45 kg, or a BMI of at least 35 to 39.9 kg with a ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of the ... been named by MedEsthetics magazine as the Best Single Physician Practice in the nation. ... many elite aesthetic physicians honored by the industry publication. , Dr. Vitenas said ...
(Date:12/1/2015)... Delaware (PRWEB) , ... December 01, 2015 , ... ... winner at the 7th Annual 2015 Golden Bridge Business Awards under the New ... is a zero capex web based sample management software that helps ...
(Date:12/1/2015)... ... 2015 , ... For many X-rays taken at hospitals, doctors’ ... by the radiologist. The marking utensils are so small, however, they are difficult ... way to alleviate this problem. , He developed the patent-pending MARK N SHOW ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... it has been awarded a fixed price per sprint agile development contract to ... at $34 million over five years, provides software engineering, infrastructure, as well as ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Pa. , Dec. 1, 2015  Today, ... announced the launch of CareFront, a first-of-its-kind population ... patients diagnosed with cancer. Designed to be built ... diagnosed cancer patients with resources for their care ... The program also offers tools to help patients ...
(Date:12/1/2015)... , Dec. 1, 2015   Craneware, ... value cycle solutions, today announced the company will ... Pharmacy ChargeLink ® solution at the ... Midyear Clinical Meeting . The new features are ... process of monitoring and managing enterprise-wide pharmacy charges ...
(Date:12/1/2015)... 1, 2015  Booth #3506 – Claymount is featuring its ... meeting of the Radiological Society of North America ... year. Based in the Netherlands , Claymount ... Systems (NYSE: VAR ) and is one of the ... solid state automatic exposure control systems for controlling dose during ...
Breaking Medicine Technology: